Physician
Hematology
Dr. Asad Bashey, MD
|
|
Give Review
Asad Bashey is an expert in the field of Hematology. He received 1 awards: "Atlanta Magazine: Top Doctors". Asad Bashey, MD is a published doctor and has 38 publications published. The lastest was: 'Patient comfort after upper abdominal surgery. Effect of routine nasogastric suction.' Asad Bashey accepts Medicare payments and is listed with Medicare.gov.
Publications
- TBI-based Myeloablative Haploidentical Stem Cell Transplantation is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sib...
- Preferential depletion of Host over donor T cells through in vivo decay of active rabbit-anti-thymocyte globulin levels during reduced intensity conditioning.
- Calcineurin Inhibitor-Free Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Brief-Course Sirolimus Following Reduced-Intensity Peri...
- T-Cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
- Preemptive DLI without withdrawal of immunosuppression to promote complete donor T-Cell chimerism results in favorable outcomes for high-risk older recipients of alemt...
- T-Cell-Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent...
- Haploidentical Transplantation Using T-Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who ...
- Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple Myeloma patients undergoing autologous transplant.
- Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide.
- Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
- Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B Cell malignancies: CALGB 109901.
- Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR Study.
- Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow Grafts versus bone marrow or peripheral blood Grafts from HLA-matched sibling donors for p...
- CTLA-4 blockade following relapse of malignancy after allogeneic stem Cell transplantation is associated with T Cell activation but not with increased levels of T regu...
- Reduced-intensity conditioning allogeneic hematopoietic Cell transplantation for patients with hematologic malignancies who relapse following autologous transplantatio...
- Race and outcomes of autologous hematopoietic Cell transplantation for multiple myeloma.
- Outcome of transplantation for myelofibrosis.
- Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from Acute myelogenous leukemia.
- CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic Cell transplantation.
- Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem Cell transplantation.
- Comparison of twin and autologous transplants for multiple Myeloma.
- Second autologous stem cell transplantation for relapsed Lymphoma after a prior autologous transplant.
- HLA-identical sibling allogeneic transplants versus chemotherapy in Acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between th...
- Peripheral blood progenitor Cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colo...
- Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis.
- Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's Macroglobulinemia.
- Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for Acute myelogenous leukemia in first rem...
- Non-anthracycline based remission induction therapy for newly diagnosed patients with Acute myeloid leukemia aged 60 or older.
- Comparison of Graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
- Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for Lymphoma: a report o...
- Autologous transplantation for diffuse aggressive non-Hodgkin Lymphoma in first relapse or second remission.
- Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular Lymphoma.
- A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic Lymphoma.
- Adenovirus transduction to effect CD40 signalling improves the Immune stimulatory activity of myeloma cells.
- Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in non-myeloablative hematopoietic Cell transpla...
- Patient comfort after upper abdominal surgery. Effect of routine nasogastric suction.
- Post-relapse survival after haploidentical transplantation vs matched-related or matched-unrelated hematopoietic Cell transplantation.
Schools
University of Dundee Faculty of Medicine Dentistry And Nursing
University Dundee
University Edinburgh
University LondonHammersmith Hospital
University Ca San Diego
Procedures Preformed
- Bone Marrow Transplant
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Breast Cancer
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Atlanta Magazine: Top Doctors
Education
-
University of California San Diego -
The University of Dundee Faculty of Medicine
Hospital
-
Northside Hospital
Drug Facts
| NPI NUMBER | 1700853363 | |
| NPPES Provider LastName | BASHEY | |
| NPPES Provider FirstName | ASAD | |
| NPPES Provider ZIPCode | 303421704 | |
| NPPES Provider State | GA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 860.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 72.0 | |
| Percent Opioid Claims | 8.37 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700853363 |
| Last Name Of The Provider | BASHEY |
| First Name Of The Provider | ASAD |
| View All |
Similar Doctors
|
|
Dr. Michael P. Fanucchi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ethan W. Tolbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clifford J. Gunthel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence E. Morris Jr., MD |
|
|
Dr. Otis W. Brawley Jr., MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. James W. Keller, MD |
|
|
Dr. Angelica G. James-Herry, MD |
|
|
Dr. Laura L. Weakland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shiyong Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean L. Koff, MD |
|
|
Dr. Amelia B. Zelnak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sara Booth, CPNP |
|
|
Pamela B. Brill, CPNP |